Home > Healthcare > Pharmaceuticals > Pharma Manufacturing > U.S. Compounding Pharmacies Market

U.S. Compounding Pharmacies Market Share

Report ID: GMI2961
Published Date: Jun 2022
Report Format: PDF

Download Free Sample

U.S. Compounding Pharmacies Market Share

Some of the key market players operating in the U.S. compounding pharmacies industry include:

Athenex Pharma Solutions (Athenex Inc.)
B Braun Melsungen AG
Clinigen Group PLC
Dougherty’s Pharmacy Inc
Fagron
Fresenius Kabi
ImprimisRx (Harrow Health, Inc.)
Institutional Pharmacy Solutions
ITC Compounding Pharmacy
Lorraine’s Pharmacy
McGuff Company Inc (McGuff Compounding Pharmacy Services)
Nephron Pharmaceuticals Corporation
Pencol Compounding Pharmacy
QuVa Pharma
Rx3 Compounding Pharmacy
Triangle Compounding Pharmacies
Wedgewood Village Pharmacy

among others. These market participants devise various strategies coupled with continuous innovations and product improvements to maintain competitive edge in the market.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The compounding pharmacies industry size in the U.S. had crossed USD 5.2 billion in 2021 and is poised to record a 5.9% CAGR through 2030 due to the surging awareness and adoption of compounded medication in the region.

The revenue of the U.S. non-sterile compounding pharmacies exceeded USD 3.5 billion in 2021 and will expand with the thriving need for modifying the route of administration based on patient convenience.

The 503B pharmacy type held close to 56.5% of the compounding pharmacies market share in the U.S. in 2021 and will grow owing to their ability to manufacture large batches of drugs for selling to healthcare facilities for office use.

The adult application segment accounted for close to 45.7% of the U.S. compounding pharmacies industry share in 2021 due to the rising prevalence of chronic diseases owing to sedentary lifestyles and food habits.